Office of Research

Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)

Limited Submissions

The purpose of the National Cancer Institute (NCI)-supported Cancer Prevention Clinical Trials Network (CP-CTNet) is to perform early phase clinical trials to evaluate the biologic effects of preventive agents and interventions and to determine clinically-relevant correlates in order to advance their development for cancer prevention.

CP-CTNet will support the following two types of components that will be individually awarded through two Notice of Funding Opportunity (NOFO) announcements indicated below:

  • CP-CTNet Site, whose role will be to design, perform and report the results of early phase (phase 0-II) cancer prevention clinical trials (this NOFO).
  • Data Management, Auditing, and Statistical Center (DMASC), which will provide centralized data management, statistical support, and auditing of clinical trials data, as well as administrative support for all CP-CTNet recipients (covered by companion NOFO, RFA-CA-24-025).

Each CP-CTNet Site will consist of a Lead Academic Organization (LAO) and Affiliated Organizations (AOs) that will work together to perform clinical trials.  Each CP-CTNet LAO will serve as the research hub for its group and will be the UG1 applicant institution. Each LAO will constitute a multi-institutional clinical trial group and provide the infrastructure to develop, implement, and analyze the studies. The Clinical trials will be performed either by the LAO and/or AOs within each CP-CTNet site or across the CP-CTNet sites (cross-network trials).

Application Instructions

Please submit:

  1. A one‐page letter of intent with a description of proposed aims and approach.
  2. If the final application requires a diversity statement or statement of broader impacts, please summarize your plans to address the specific requirements on an additional page.
  3. CV (not biosketch) of the PI including past grant funding.

to limitedsubs@uw.edu by 5:00 PM Wednesday, September 25, 2024. Proposals are due to the sponsor 10/31/2024, so you will need to have your materials in to the Office of Sponsored Programs by 10/22/2024 if given the go‐ahead by the Limited Submissions review committee.

Opportunity Details

Program web page

Program Announcement No.

RFA-CA-24-024

Deadlines
09/25/2024 UW Internal Deadline Closed
10/22/2024 OSP Deadline
10/31/2024 Sponsor Deadline
Sponsor

National Institutes of Health (NIH)

Funding amount

$1,375,000 (in direct costs per year for 6 years)

Maximum Number of Applications

1

Eligible groups
  • All campus

Inquiries and Contact Information

Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.

For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at limitedsubs@uw.edu.